15.01.2013 Views

E_mg_GB_03_vorne-29_3_04

E_mg_GB_03_vorne-29_3_04

E_mg_GB_03_vorne-29_3_04

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>mg</strong> engineering<br />

GEA 20<strong>03</strong>* 2001/02* SFY 2002*<br />

u million s million s million<br />

Sales 2,702 2,874 607<br />

EBITDA 253 <strong>29</strong>3 48<br />

EBIT (1) 199 241 36<br />

Pre-tax earnings (1) Depreciation and amortization<br />

197 235 36<br />

of fixed assets (1) 54 52 12<br />

Capital expenditure (2) Net cash provided by (used for)<br />

50 66 17<br />

operating activities 209 165 – 35<br />

New orders 2,665 2,847 638<br />

Order book 891 1,000 1,017<br />

Employees (3) 13,820 14,080 14,096<br />

Share of consolidated sales 42.2%<br />

Lurgi Lentjes 20<strong>03</strong> 2001/02 SFY 2002<br />

u million s million s million<br />

Sales 361 486 1<strong>04</strong><br />

EBITDA – 112 – 6 – 3<br />

EBIT – 123 – 8 – 3<br />

Pre-tax earnings<br />

Depreciation and amortization<br />

– 124 – 6 – 3<br />

of fixed assets 11 3 0<br />

Capital expenditure (2) Net cash used for<br />

2 4 0<br />

operating activities – 125 – 57 – 9<br />

New orders 538 408 208<br />

Order book 646 502 597<br />

Employees (3) 566 647 601<br />

Share of consolidated sales 5.6%<br />

<strong>mg</strong> chemical group<br />

Share of consolidated sales 36.4%<br />

*) Figures for GEA have been adjusted<br />

for discontinued operations<br />

Dynamit Nobel 20<strong>03</strong>* 2001/02* SFY 2002*<br />

u million s million s million<br />

Sales 2,328 2,461 561<br />

EBITDA 3<strong>29</strong> 398 74<br />

EBIT (1) 214 279 46<br />

Pre-tax earnings (1) Depreciation and amortization<br />

188 249 38<br />

of fixed assets (1) 115 119 28<br />

Capital expenditure (2) Net cash provided by<br />

198 179 41<br />

operating activities 272 288 43<br />

Employees (3) 12,3<strong>04</strong> 12,596 12,555<br />

*) Figures for Dynamit Nobel have been<br />

adjusted for discontinued operations<br />

Lurgi 20<strong>03</strong> 2001/02 SFY 2002<br />

u million s million s million<br />

Sales 592 497 1<strong>29</strong><br />

EBITDA – 73 2 1<br />

EBIT – 86 – 8 – 1<br />

Pre-tax earnings<br />

Depreciation and amortization<br />

– 76 8 3<br />

of fixed assets 13 10 2<br />

Capital expenditure (2) Net cash used for<br />

2 5 0<br />

operating activities – 64 – 43 – 42<br />

New orders 2<strong>29</strong> 577 36<br />

Order book 417 833 745<br />

Employees (3) 1,266 1,425 1,4<strong>29</strong><br />

Share of consolidated sales 9.2%<br />

Zimmer 20<strong>03</strong> 2001/02 SFY 2002<br />

u million s million s million<br />

Sales 223 263 59<br />

EBITDA 2 9 3<br />

EBIT (1) 0 7 2<br />

Pre-tax earnings (1) Depreciation and amortization<br />

4 16 4<br />

of fixed assets (1) 2 2 0<br />

Capital expenditure (2) Net cash provided by<br />

21 5 1<br />

operating activities 11 14 2<br />

New orders 220 225 55<br />

Order book 237 235 228<br />

Employees (3) 719 362 359<br />

Share of consolidated sales 3.5%<br />

(1) The <strong>mg</strong> Group started to use push-down accounting at the beginning of 20<strong>03</strong>; this has resulted in higher depreciation and amortization<br />

in the GEA (P5.3 million), Dynamit Nobel (P1.9 million) and Zimmer (P0.6 million) segments as from fiscal 20<strong>03</strong>.<br />

(2) Purchases of property, plant and equipment and intangible assets and investments (including capital leases)<br />

(3) Full-time equivalents (FTEs), excluding trainees, at the balance sheet date<br />

solvadis 20<strong>03</strong>* 2001/02* SFY 2002*<br />

u million s million s million<br />

Sales 1,416 1,441 426<br />

EBITDA 0 35 6<br />

EBIT – 6 28 5<br />

Pre-tax earnings<br />

Depreciation and amortization<br />

– 7 28 4<br />

of fixed assets 6 7 1<br />

Capital expenditure (2) Net cash used for<br />

10 31 3<br />

operating activities – 21 39 – 25<br />

Employees (3) 792 838 835<br />

*) Figures of solvadis only for information purposes<br />

(discontinued operations)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!